欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号MT/H/0688/001
药品名称Hydromorphone Aristo 2.6mg/ml oral solution
活性成分
    • Hydromorphone hydrochloride 2.6 mg/ml
剂型Oral solution
上市许可持有人Aristo Pharma GmbH D-13435 Berlin, Wallenroder Str. 8-10, Berlin, 13435, Germany
参考成员国 - 产品名称Malta (MT)
Hydromorphone Aristo 2.6mg/ml oral solution
互认成员国 - 产品名称
    • Germany (DE)
      Hydromorphon Aristo 2,6 mg/ml Lösung zum Einnehmen
    • Spain (ES)
许可日期2025/01/08
最近更新日期2025/05/16
药物ATC编码
    • N02AA03 hydromorphone
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Hybrid application (Art 10.3 Dir 2001/83/EC)
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase